rs7194

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_019111.5(HLA-DRA):​c.*63G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.616 in 151,856 control chromosomes in the GnomAD database, including 29,199 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.62 ( 29198 hom., cov: 30)
Exomes 𝑓: 0.75 ( 1 hom. )

Consequence

HLA-DRA
NM_019111.5 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.779

Publications

59 publications found
Variant links:
Genes affected
HLA-DRA (HGNC:4947): (major histocompatibility complex, class II, DR alpha) HLA-DRA is one of the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha and a beta chain, both anchored in the membrane. This molecule is expressed on the surface of various antigen presenting cells such as B lymphocytes, dendritic cells, and monocytes/macrophages, and plays a central role in the immune system and response by presenting peptides derived from extracellular proteins, in particular, pathogen-derived peptides to T cells. The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. DRA does not have polymorphisms in the peptide binding part and acts as the sole alpha chain for DRB1, DRB3, DRB4 and DRB5. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.723 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_019111.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HLA-DRA
NM_019111.5
MANE Select
c.*63G>A
3_prime_UTR
Exon 5 of 5NP_061984.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HLA-DRA
ENST00000395388.7
TSL:6 MANE Select
c.*63G>A
3_prime_UTR
Exon 5 of 5ENSP00000378786.2
HLA-DRA
ENST00000374982.5
TSL:6
c.*63G>A
3_prime_UTR
Exon 5 of 5ENSP00000364121.5
ENSG00000299747
ENST00000766007.1
n.163-6443C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.616
AC:
93521
AN:
151734
Hom.:
29179
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.597
Gnomad AMI
AF:
0.782
Gnomad AMR
AF:
0.672
Gnomad ASJ
AF:
0.747
Gnomad EAS
AF:
0.707
Gnomad SAS
AF:
0.742
Gnomad FIN
AF:
0.517
Gnomad MID
AF:
0.728
Gnomad NFE
AF:
0.605
Gnomad OTH
AF:
0.651
GnomAD4 exome
AF:
0.750
AC:
3
AN:
4
Hom.:
1
Cov.:
0
AF XY:
0.750
AC XY:
3
AN XY:
4
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AF:
1.00
AC:
2
AN:
2
European-Non Finnish (NFE)
AF:
0.500
AC:
1
AN:
2
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.675
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.616
AC:
93583
AN:
151852
Hom.:
29198
Cov.:
30
AF XY:
0.617
AC XY:
45827
AN XY:
74218
show subpopulations
African (AFR)
AF:
0.597
AC:
24719
AN:
41404
American (AMR)
AF:
0.672
AC:
10260
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.747
AC:
2589
AN:
3466
East Asian (EAS)
AF:
0.707
AC:
3637
AN:
5146
South Asian (SAS)
AF:
0.743
AC:
3569
AN:
4802
European-Finnish (FIN)
AF:
0.517
AC:
5440
AN:
10518
Middle Eastern (MID)
AF:
0.721
AC:
212
AN:
294
European-Non Finnish (NFE)
AF:
0.605
AC:
41069
AN:
67928
Other (OTH)
AF:
0.653
AC:
1378
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1789
3578
5367
7156
8945
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
784
1568
2352
3136
3920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.622
Hom.:
59454
Bravo
AF:
0.627
Asia WGS
AF:
0.693
AC:
2411
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.91
DANN
Benign
0.22
PhyloP100
-0.78
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7194; hg19: chr6-32412480; API